Results 61 to 70 of about 1,140,114 (148)
Therapeutics Letter 66 provides an update on the prescription drug treatments for overactive bladder that were previously reviewed in Therapeutics Letter 57.
Therapeutics Initiative (University of British Columbia)
core +1 more source
Therapeutics Letter 82 highlights five Cochrane systematic reviews about hypertension, which provide clear clinical evidence to direct patient care. Interventions reviewed include relaxation therapies, beta blockers, calcium channel blockers, first-line ...
Therapeutics Initiative (University of British Columbia)
core +1 more source
Therapeutics Letter 74 examines the increasing use of antipsychotics in children. The use of antipsychotics in children and adolescents remains controversial.
Therapeutics Initiative (University of British Columbia)
core +1 more source
Heart Regeneration and Repair: Molecular Mechanism and Therapeutic Targets
The substantial loss of cardiomyocytes resulting from myocardial infarction leads to pathological remodeling of the heart and the onset of heart failure.
Mingchuan Liu +9 more
doaj +1 more source
Therapeutics Letter 136 examines conflicts of interest in primary care and the pharmaceutical industry. Conclusions: Industry sponsorship of clinical trials can lead to biased conclusions, including exaggerated claims of efficacy and underestimation of ...
Therapeutics Initiative (University of British Columbia)
core
The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies
Aging is a complex biological process that significantly influences human health, including susceptibility to cancer. Although aging and cancer are distinct phenomena, they intersect through shared molecular mechanisms such as genomic instability ...
Liangce Wang +4 more
doaj +1 more source
Therapeutics Letter 28 explores the role of angiotensin II receptor blockers in hypertension and congestive heart failure. Conclusions: Angiotensin receptor blockers act to modulate the renin angiotensin pathway at a different site compared to ACE ...
Therapeutics Initiative (University of British Columbia)
core +1 more source
Therapeutics Letter 7 examines drugs of choice for the treatment of hypertension. Conclusions: based on the evidence available at this time and using criteria of effectiveness and cost, thiazides are clearly the drug of first choice.
Therapeutics Initiative (University of British Columbia)
core +1 more source
Therapeutics Letter 1 addresses common questions, including dosage, about H2-blockers for treatment of non-ulcer dyspepsia in adults. Other than cost, there is little difference between the four H2-blockers (Cimetidine, Famotidine, Nizatidine, and ...
Therapeutics Initiative (University of British Columbia)
core
The effectiveness of digital therapeutics in improving sleep quality: a systematic review and network meta-analysis. [PDF]
Tong Z +9 more
europepmc +1 more source

